Valeur Intrinsèque du S&P et Nasdaq Contactez-nous

M3, Inc. MTHRY OTC

Other OTC • Healthcare • Medical - Healthcare Information Services • JP • USD

SharesGrow Score
79/100
4/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

M3, Inc. (MTHRY) est une société cotée en bourse dans le Santé secteur, opérant dans le Medical - Healthcare Information Services secteur d'activité. Le siège social de l'entreprise est situé à Tokyo, Japan. Le PDG actuel est Itaru Tanimura.

MTHRY a date d'introduction en bourse 2020-06-29, 12,100 employés à temps plein, cotée sur le Other OTC, une capitalisation boursière de $6.84B.

À propos de M3, Inc.

M3, Inc. is a Tokyo-based healthcare services company that provides digital platforms and solutions primarily to physicians, healthcare professionals, and pharmaceutical companies across multiple markets. The company operates five main business segments: Medical Platform, which includes its flagship m3.com membership portal and consumer health platform AskDoctors; Evidence Solution, offering medical information and research tools; Career Solution, providing recruitment and career services for doctors and pharmacists; Site Solution, delivering electronic medical records and marketing support for pharmaceutical institutions; and Overseas operations, which include MDLinx in the United States and regional drug information services in Europe. Beyond digital platforms, M3 also generates revenue through pharmaceutical sales support, clinical trial operations, healthcare staffing services, and management consulting for medical institutions.

📍 Akasaka Intercity, Tokyo 107-0052 📞 81 3 6229 8900
Détails de l'Entreprise
SecteurSanté
IndustrieMedical - Healthcare Information Services
PaysJapan
BourseOther OTC
DeviseUSD
Date d'IPO2020-06-29
PDGItaru Tanimura
Employés12,100
Informations de Trading
Prix Actuel$5.05
Capitalisation Boursière$6.84B
Plage 52 Semaines4.73-8.85
Bêta0.52
ETFNon
ADROui
CUSIP55379N106
Contactez-nous
🎓
SharesGrow Académie
Apprenez à calculer la Valeur Intrinsèque et trouver des actions sous-évaluées.
Sessions hebdomadaires en direct
Envoyez-nous un message